Disrupted Serotonergic and Sympathoadrenal Systems in Patients with Chronic Heart Failure May Serve as New Therapeutic Targets and Novel Biomarkers to Assess Severity, Progression and Response to Treatment

Publisher： Karger

E-ISSN： 1421-9751|113|4|277-286

ISSN： 0008-6312

Source： Cardiology, Vol.113, Iss.4, 2009-03, pp. : 277-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonergic and Sympatho-Adrenal Systems in Heart Failure: An Old but Still Alive Pathway

By  

Cardiology, Vol. 113, Iss. 4, 2009-03 ,pp. : 274-276

Karger

Access to resources Recommend Favorite

Ion channels as novel therapeutic targets in heart failure

By Akar Fadi   Tomaselli Gordon  

Annals of Medicine, Vol. 37, Iss. 1, 2005-03 ,pp. : 44-54

Informa Healthcare

Access to resources Recommend Favorite

Failure of Platelet Parameters and Biomarkers to Correlate Platelet Function to Severity and Etiology of Heart Failure in Patients Enrolled in the EPCOT Trial

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 8-15

Karger

Access to resources Recommend Favorite

Association of nutritional risk index with metabolic biomarkers, appetite‐regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 68, Iss. 11, 2014-11 ,pp. : 1293-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite

New and emerging biomarkers of heart failure

By Clerico Aldo   Vittorini Simona   Passino Claudio   Emdin Michele  

Critical Reviews in Clinical Laboratory Sciences, Vol. 46, Iss. 3, 2009-06 ,pp. : 107-128

Informa Healthcare

Access to resources Recommend Favorite